Windlas Biotech Ltd Half Yearly Results

Gross Sales

397.72

362.15

333.5

297.46

260.42

Excise Duty

0

0

0

0

0

Net Sales

397.72

362.15

333.5

297.46

260.42

Other Operating Income

0

0

0

0

0

Other Income

9.04

8.97

7.6

5.86

4.5

Total Income

406.77

371.13

341.1

303.32

264.91

Total Expenditure

347.55

318.23

291.16

261.63

230.03

PBIDT

59.22

52.9

49.95

41.69

34.89

Interest

2.79

1.6

0.58

0.52

0.32

PBDT

56.44

51.31

49.36

41.17

34.56

Depreciation

15.27

12.71

6.93

6.52

6.7

Minority Interest Before NP

0

0

0

0

0

Tax

8.55

9.74

9.02

8.35

6.98

Deferred Tax

0.76

-0.28

1.33

0.2

0.25

Reported Profit After Tax

31.86

29.14

32.09

26.1

20.63

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

31.86

29.14

32.09

26.1

20.63

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

31.86

29.14

32.09

26.1

20.63

EPS (Unit Curr.)

15.2

13.67

15.43

12.54

9.86

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.48

10.45

10.4

10.4

10.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.88

14.6

14.97

14.01

13.39

PBDTM(%)

-

-

-

-

-

PATM(%)

8.01

8.04

9.62

8.77

7.92